Finoriq research workspace

Edwards Lifesciences Corp (EW) Company Overview

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular. Review EW filings, fundamentals, valuation, and ownership on Finoriq.

Company Snapshot

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Company

Edwards Lifesciences Corp (EW)

Ticker

EW

Market Cap

$49B

Latest Price

$85.14

Industry

Industrial Specialties

Open insider transactions

Edwards Lifesciences Corp (EW) Current Valuation Metrics

Static valuation preview for Edwards Lifesciences Corp (EW). Market data retrieved 2026-07-07. Filing currency USD.

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.